Involvement of kinins, mast cells and sensory neurons in the plasma exudation and paw oedema induced by staphylococcal enterotoxin B in the mouse

European Journal of Pharmacology

Volumn 399, Issue 2-3, 2000, Pages 235-242

  Linardi, Alessandra ^a   Costa, Soraia K P ^a   Da Silva, Glaci Ribeiro ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Kinin; Mast cell; Neurogenic inflammation; Staphylococcal enterotoxin B; Tachykinin NK1 receptor; Vanilloid receptor

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; CAPSAZEPINE; ICATIBANT; MEPYRAMINE; METHYSERGIDE; STAPHYLOCOCCUS ENTEROTOXIN B; TACHYKININ; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; INFLAMMATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; SENSORY NERVE;

ANIMALS; BENZAMIDES; BRADYKININ; CAPILLARY PERMEABILITY; CAPSAICIN; DIABETES MELLITUS, EXPERIMENTAL; EDEMA; ENTEROTOXINS; HINDLIMB; KININS; MALE; MAST CELLS; MICE; NEURONS, AFFERENT; PIPERIDINES; PYRILAMINE; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2;

EID: 0034617364     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00375-7     Document Type: Article

References (58)

1. Aly R., Maibach H.I., Shinefield H.R. Microbial flora of atopic dermatitis. Arch. Dermatol. 113:1997;780-782.
2. Amann R., Schuligoi R., Lanz I., Donnerer J. Histamine-induced edema in the rat paw-effect of capsaicin denervation and a CGRP receptor antagonist. Eur. J. Pharmacol. 279:1995;227-231.
3. Bennett G.S., Garret N.E., Diemel L.T., Brain S.D., Tomlinson D.R. Neurogenic cutaneous vasodilation and plasma extravasation in diabetic rats: effects of insulin and nerve growth factor. Br. J. Pharmacol. 124:1998;1573-1579.
4. Bergdoll M.S. Enterotoxins. Ajl S.J., Montie T.C., Kadis S. Microbial Toxins. 1970;559-593 Academic Press, New York.
5. Bergdoll M.S. Staphylococcal intoxications. Reimann H., Bryan F.L. Foodborne Infections and Intoxications. 1979;443-494 Academic Press, New York.
6. Bevan S., Hothi S., Hughes G.A., James I.F., Rang H.P., Shah K., Walpole C.S.J., Yeats J.C. Development of a competitive antagonist for the sensory neurone excitant capsaicin. Br. J. Pharmacol. 102:1991;77P-85P.
7. Brain S.D., Williams T.J. Interaction the tachykinin and calcitonin gene-related peptide lead to the modulation of oedema and blood flow in rat skin. Br. J. Pharmacol. 97:1989;77-82.
8. Cellier E., Barbot L., Iyengar S., Couture R. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br. J. Pharmacol. 127:1999;717-728.
9. Costa S.K.P., Moreno H. Jr., Brain S.D., De Nucci G., Antunes E. The effect of Phoneutria nigriventer (armader spider) venom on arterial blood pressure of anaesthetised rat. Eur. J. Pharmacol. 298:1996;113-120.
10. De Bie J.J., Henricks P.A., Cruikshank W.W., Hofman G., Jonker E.H., Nijkamp F.P., Van Oosterhout A.J. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma. Br. J. Pharmacol. 124:1998;857-864.
11. Desouza I.A., Bergdoll M.S., Ribeiro-DaSilva G. Pharmacological characterization of mouse paw edema induced by Staphylococcal enterotoxin B. J. Nat. Toxins. 5:1996;61-71.
12. Devillier P., Drapeau G., Renoux M., Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. Eur. J. Pharmacol. 168:1989;53-60.
13. Dicky P.J. New understanding and treatment of diabetic neuropathy. N. Engl. J. Med. 326:1992;1287-1288.
14. Dray A., Perkins M.N. Bradykinin activates peripheral capsaicin-sensitive fibres via a second messenger system. Agents Actions. 25:1988;214-215.
15. Dray A., Perkins M.N. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
16. 2) receptor. Life Sci. 50:1992;PL101-PL106.
17. 1 receptor antagonist. Eur. J. Pharmacol. 250:1993;403-413.
18. Fortes Z.B., Garcia-Leme J., Schivoletto R. Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br. J. Pharmacol. 83:1984;635-643.
19. Fox A.J., Urbán L., Barnes P., Dray A. Effect of capsazepine against capsaicin- and proton-evoked excitation of single airways C fibres and vagus nerve from the guine pig. Neuroscience. 67:1995;741-752.
20. Gamsé R., Jancsò G. Reduced neurogenic changes in inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion. Eur. J. Pharmacol. 118:1985;175-180.
21. Gamsé R., Holzer P., Lembeck F. Decrease of substance P in primary afferent neurons and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Pharmacol. 68:1980;207-213.
22. Gamsé R., Leeman S.E., Holzer P., Lembeck F. Differential effects of capsaicin on the content of somatostatin, substance P and neurotensin in the nervous system of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;140-148.
23. Garcia-Leme J., Fortes Z.B., Sannomya P., Farsky S.P. Autacoid Pharmacology. 1992;99-118 Verlag Basel, Birkhäuser.
24. Geppetti P. Sensory neuropeptides release by bradykinin: mechanisms and pathophysiological implications. Regul. Pept. 47:1993;1-23.
25. Geppetti P., Tramontana M., Santicioli P., Del Bianco E., Giuliani S., Maggi C.A. Bradykinin-induced release of CGRP from capsaicin-sensitive nerves in guinea-pig atria: mechanism of action and calcium requirements. Neuroscience. 38:1990;687-692.
26. Gottfried A., Scheuber P.H., Bernhard R., Sailer-Kramer B., Hartmann A. Role of substance P in immediate-type skin reactions induced by Staphylococcal enterotoxin B unsensitized monkeys. J. Allergy Clin. Immunol. 84:1989;880-885.
27. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:1991;143-201.
28. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchic vascular beds. Rev. Physiol. Biochem. Pharmacol. 121:1992;49-146.
29. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 30:1998;5-11.
30. Hua X.Y., Wong S., Jinno S., Yaksh T. Pharmacology of calcitonin gene related from sensory terminals in the rat trachea. Can. J. Physiol. Pharmacol. 73:1995;99-1006.
31. Inoue H., Asaka T., Nagata N., Koshihara Y. Mechanism of mustard oil-induced skin inflammation in mice. Eur. J. Pharmacol. 333:1997;231-240.
32. Jancsó N., Jancsó-Gábor A., Szolcsányi J. Direct evidence for neurogenic inflammation and it's prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. Chemother. 31:1967;138-151.
33. Komisar J., Rivera J., Veja A., Tseng J. Effects of Staphylococcal B on rodent mast cells. Infect. Immun. 60:1992;1969-2975.
34. Kowalski M.L., Sliwinska-Kowalska M., Kaliner M.A. Neurogenic inflammation, vascular permeability, and mast cells: II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation. J. Immunol. 145:1990;1214-1221.
35. 2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides. 21:1992;65-72.
36. Lever R., Hadley K., Downey D., Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br. J. Dermatol. 119:1988;189-198.
37. Levy L. Carragenan paw edema in the mouse. Life Sci. 8:1969;601-606.
38. Levy D.M., Terenghi G., Gu X.H., Abrahan R.R., Springal D.R., Polak J.M. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neuronal function. Diabetologia. 35:1992;889-897.
39. Maggi C.A., Meli A. The sensory-efferent function of capsaicin-sensitive neurons. Gen. Pharmacol. 19:1988;1-43.
40. Micusan V.V., Thibodeau J. Superantigens of microbial origin. Semin. Immunol. 5:1993;3-11.
41. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P.H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphycococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:1992;91-98.
42. Moura S.R., Aguiar A.S., Melgarejo A.R., Carvalho L.C.R.M. Pharmacological aspects of mouse hind-paw oedema induced by Lachesis muta rhombeata venom. Toxicon. 36:1998;771-780.
43. Ottlecz A., Koltal M., Dekov E. Effect of insulin and alloxan diabetes on carrageenan inflammation in rats. Int. Arch. Allergy Appl. Immunol. 50:1976;548-554.
44. Palframan R.T., Costa S.K., Wilsoncroft P., Antunes E., De Nucci G., Brain S.D. The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider. Br. J. Pharmacol. 118:1996;295-298.
45. Perkins M.N., Campbell E.A. Capsazepine reversal of the antinociceptive action of capsaicin in vivo. Br. J .Pharmacol. 107:1992;329-333.
46. 1 receptor-mediated neutrophil accumulation in the rat cutaneous microvasculature by thermal injury. Eur. J. Pharmacol. 369:1999;91-98.
47. Ptak W., Czanik Z., Hanczakowska M. Contact sensitivity in alloxan diabetic mice. Clin. Exp. Immunol. 19:1975;319-326.
48. 1 receptor. Part I: Ligands and mechanism of cellular activation. Neuropeptides. 31:1997;537-563.
49. 1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides. 32:1998;1-49.
50. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
51. Ridger V.C., Greenacre S.A, Handy R.L., Halliwell B., Moore P.K., Whiteman M., Brain S.D. Effect of peroxynitrite on plasma extravasation, microvascular blood flow and nociception in the rat. Br. J. Pharmacol. 122:1997;1083-1088.
52. A receptor antagonist inhibits allergic inflammation in the mouse. J. Cardiovasc. Pharmacol. 26:1995;S416-S418.
53. Santos A.R.S., Calixto J.B. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides. 31:1997;381-389.
54. Szikszay M., Sándor B., Gyongyi H., Gyogy B. Multiple nitric oxide sources in neurogenic plasma extravasation in rat hind paw skin. Life Sci. 63:1998;1119-1125.
55. Tratsk K.S., Campos M.M., Vaz S.R., Filho V.C., Schlemper V., Yunes R.A., Calixto J.B. Antiallergic effects and oedema inhibition caused by the extract of Drymis winteric. Inflammation Res. 46:1997;509-514.
56. Vogel R. Bradykinin, kallidin and kallikrein. Handbook Exp. Pharmacol. 1979;163-225 Springer-Verlag, Berlin.
57. Walsh L.J., Davis M.F., Xu L.J., Savage N.W. Relationship between mast cell degranulation and inflammation in the oral cavity. J. Oral Pathol. Med. 24:1995;266-272.
58. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henke St., Breipohl G., Konig W., Knolle J., Scholkens B.A. Hoe 140 a new potent and long acting bradykinin antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.